Acyclovir use and survival among human immunodeficiency virus-infected patients with CD4 cell counts of 3

Ramón A. Torres, James D. Neaton, Deborah N. Wentworth, Michael R. Barr, Donald Abrams, Renslow Sherer, Thomas Ward, James Sampson

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

To examine the relationship between acyclovir use and survival in AIDS, we performed a retrospective analysis of data collected through an observational cohort of the 17-site Community Program for Clinical Research on AIDS (CPCRA), under the sponsorship of the National Institute of Allergy and Infectious Diseases. Data were analyzed regarding 2,368 patients with CD4~ lymphocyte counts of 3, and 7,836 follow-up visits were conducted from September 1990 to July 1994. Factors associated with use of acyclovir were studied by stratified analysis of variance and Mantel-Haenzel χ2 rests. The association between acyclovir and survival was studied with use of the proportional hazards regression model. Individuals reporting acyclovir use were more likely to be white, male, and homosexual; to have a history of herpes simplex and zoster; and to have lower CD4*T cell counts than those who did not. After adjustments for differences in baseline factors, acyclovir use was not associated with prolonged survival.

Original languageEnglish (US)
Pages (from-to)85-90
Number of pages6
JournalClinical Infectious Diseases
Volume26
Issue number1
StatePublished - 1998
Externally publishedYes

Fingerprint

Acyclovir
CD4 Lymphocyte Count
HIV
Survival
Acquired Immunodeficiency Syndrome
National Institute of Allergy and Infectious Diseases (U.S.)
Herpes Simplex
Herpes Zoster
Proportional Hazards Models
Analysis of Variance
T-Lymphocytes
Research

ASJC Scopus subject areas

  • Immunology

Cite this

Torres, R. A., Neaton, J. D., Wentworth, D. N., Barr, M. R., Abrams, D., Sherer, R., ... Sampson, J. (1998). Acyclovir use and survival among human immunodeficiency virus-infected patients with CD4 cell counts of 3 . Clinical Infectious Diseases, 26(1), 85-90.

Acyclovir use and survival among human immunodeficiency virus-infected patients with CD4 cell counts of 3 . / Torres, Ramón A.; Neaton, James D.; Wentworth, Deborah N.; Barr, Michael R.; Abrams, Donald; Sherer, Renslow; Ward, Thomas; Sampson, James.

In: Clinical Infectious Diseases, Vol. 26, No. 1, 1998, p. 85-90.

Research output: Contribution to journalArticle

Torres, RA, Neaton, JD, Wentworth, DN, Barr, MR, Abrams, D, Sherer, R, Ward, T & Sampson, J 1998, 'Acyclovir use and survival among human immunodeficiency virus-infected patients with CD4 cell counts of 3 ', Clinical Infectious Diseases, vol. 26, no. 1, pp. 85-90.
Torres RA, Neaton JD, Wentworth DN, Barr MR, Abrams D, Sherer R et al. Acyclovir use and survival among human immunodeficiency virus-infected patients with CD4 cell counts of 3 . Clinical Infectious Diseases. 1998;26(1):85-90.
Torres, Ramón A. ; Neaton, James D. ; Wentworth, Deborah N. ; Barr, Michael R. ; Abrams, Donald ; Sherer, Renslow ; Ward, Thomas ; Sampson, James. / Acyclovir use and survival among human immunodeficiency virus-infected patients with CD4 cell counts of 3 . In: Clinical Infectious Diseases. 1998 ; Vol. 26, No. 1. pp. 85-90.
@article{37909375b31d479faba49239304d2063,
title = "Acyclovir use and survival among human immunodeficiency virus-infected patients with CD4 cell counts of 3",
abstract = "To examine the relationship between acyclovir use and survival in AIDS, we performed a retrospective analysis of data collected through an observational cohort of the 17-site Community Program for Clinical Research on AIDS (CPCRA), under the sponsorship of the National Institute of Allergy and Infectious Diseases. Data were analyzed regarding 2,368 patients with CD4~ lymphocyte counts of 3, and 7,836 follow-up visits were conducted from September 1990 to July 1994. Factors associated with use of acyclovir were studied by stratified analysis of variance and Mantel-Haenzel χ2 rests. The association between acyclovir and survival was studied with use of the proportional hazards regression model. Individuals reporting acyclovir use were more likely to be white, male, and homosexual; to have a history of herpes simplex and zoster; and to have lower CD4*T cell counts than those who did not. After adjustments for differences in baseline factors, acyclovir use was not associated with prolonged survival.",
author = "Torres, {Ram{\'o}n A.} and Neaton, {James D.} and Wentworth, {Deborah N.} and Barr, {Michael R.} and Donald Abrams and Renslow Sherer and Thomas Ward and James Sampson",
year = "1998",
language = "English (US)",
volume = "26",
pages = "85--90",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Acyclovir use and survival among human immunodeficiency virus-infected patients with CD4 cell counts of 3

AU - Torres, Ramón A.

AU - Neaton, James D.

AU - Wentworth, Deborah N.

AU - Barr, Michael R.

AU - Abrams, Donald

AU - Sherer, Renslow

AU - Ward, Thomas

AU - Sampson, James

PY - 1998

Y1 - 1998

N2 - To examine the relationship between acyclovir use and survival in AIDS, we performed a retrospective analysis of data collected through an observational cohort of the 17-site Community Program for Clinical Research on AIDS (CPCRA), under the sponsorship of the National Institute of Allergy and Infectious Diseases. Data were analyzed regarding 2,368 patients with CD4~ lymphocyte counts of 3, and 7,836 follow-up visits were conducted from September 1990 to July 1994. Factors associated with use of acyclovir were studied by stratified analysis of variance and Mantel-Haenzel χ2 rests. The association between acyclovir and survival was studied with use of the proportional hazards regression model. Individuals reporting acyclovir use were more likely to be white, male, and homosexual; to have a history of herpes simplex and zoster; and to have lower CD4*T cell counts than those who did not. After adjustments for differences in baseline factors, acyclovir use was not associated with prolonged survival.

AB - To examine the relationship between acyclovir use and survival in AIDS, we performed a retrospective analysis of data collected through an observational cohort of the 17-site Community Program for Clinical Research on AIDS (CPCRA), under the sponsorship of the National Institute of Allergy and Infectious Diseases. Data were analyzed regarding 2,368 patients with CD4~ lymphocyte counts of 3, and 7,836 follow-up visits were conducted from September 1990 to July 1994. Factors associated with use of acyclovir were studied by stratified analysis of variance and Mantel-Haenzel χ2 rests. The association between acyclovir and survival was studied with use of the proportional hazards regression model. Individuals reporting acyclovir use were more likely to be white, male, and homosexual; to have a history of herpes simplex and zoster; and to have lower CD4*T cell counts than those who did not. After adjustments for differences in baseline factors, acyclovir use was not associated with prolonged survival.

UR - http://www.scopus.com/inward/record.url?scp=0031941401&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031941401&partnerID=8YFLogxK

M3 - Article

C2 - 9455514

AN - SCOPUS:0031941401

VL - 26

SP - 85

EP - 90

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 1

ER -